Lantern Pharma Inc. (LTRN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 7.06M | 10.8B | 13.46M | 17.2M | 20.82M | 25.25M | 29.92M | 35.29M | 39.47M | 43.34M | 47.43M | 51.04M | 55.17M | 58.72M | 62.02M | 65.66M | 67.66M | 72.72M | 76.34M | 82.13M |
| Cash & Short-Term Investments | 6.32M | 10.12B | 12.36M | 15.9M | 19.72M | 24.01M | 28.05M | 33.26M | 38.36M | 41.3M | 44.93M | 47.95M | 52.08M | 55.2M | 58.37M | 62.15M | 65.22M | 70.73M | 73.83M | 79.59M |
| Cash Only | 4.92M | 4.42B | 8.39M | 6.06M | 6.38M | 7.51M | 8.1M | 12.98M | 18.36M | 21.94M | 25.57M | 28.42M | 33.02M | 37.2M | 39.8M | 43.36M | 46.65M | 51.52M | 54.67M | 61.35M |
| Short-Term Investments | 1.41M | 5.7B | 3.97M | 9.84M | 13.34M | 16.5M | 19.95M | 20.29M | 20M | 19.36M | 19.35M | 19.53M | 19.06M | 17.99M | 18.57M | 18.79M | 18.56M | 19.2M | 19.16M | 18.23M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 860K | 0 | 0 | 0 | 0 | 305K | 0 | 0 | 181K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 734.41K | 683.95M | 1.1M | 1.3M | 1.1M | 1.23M | 1.87M | 2.03M | 1.11M | 745.65K | 2.5M | 3.09M | 3.09M | 541.18K | 2.58M | 0 | 0 | 378.95K | 0 | 0 |
| Total Non-Current Assets | 165.81K | 232.64M | 165.81K | 219.5K | 272.96K | 324.16K | 372.3K | 295.35K | 263.36K | 306.29K | 345.53K | 384.07K | 341.75K | 113.58K | 144.62K | 716.82K | 739.36K | 1.23M | 1.27M | 300.99K |
| Property, Plant & Equipment | 84.89K | 107.47M | 129.07K | 182.76K | 236.22K | 287.43K | 335.57K | 263.34K | 237.49K | 280.42K | 319.66K | 358.2K | 308.79K | 95.69K | 126.73K | 157.75K | 180.29K | 216.19K | 251.67K | 283.1K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 0 |
| Other Non-Current Assets | 80.92K | 125.17M | 36.74K | 36.74K | 36.74K | 36.74K | 36.74K | 32.02K | 25.87K | 25.87K | 25.87K | 25.87K | 32.97K | 17.89K | 17.89K | 559.07K | 559.07K | 17.89K | 1.02M | 17.89K |
| Total Assets | 7.22M | 11.04B | 13.63M | 17.42M | 21.1M | 25.57M | 30.29M | 35.59M | 39.73M | 43.65M | 47.77M | 51.43M | 55.51M | 58.84M | 62.16M | 66.38M | 68.4M | 73.95M | 77.61M | 82.43M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -65.76% | 43056.19% | -55.02% | -51.05% | -46.91% | -41.41% | -36.59% | -30.8% | -28.42% | -25.82% | -23.15% | -22.53% | -18.85% | -20.44% | -19.9% | -19.47% | -17.09% | 263.22% | 245.02% | 221.84% |
| Total Current Liabilities | 3.78M | 4.5B | 4.04M | 4.88M | 4.29M | 4.33M | 3.6M | 4.6M | 3.95M | 2.68M | 2.25M | 3.02M | 2.79M | 2.8M | 3.14M | 5.3M | 3.07M | 2.33M | 1.79M | 2.69M |
| Accounts Payable | 0 | 0 | 3.95M | 4.75M | 4.12M | 0 | 0 | 0 | 0 | 942.21K | 0 | 0 | 2.67M | 0 | 3.05M | 0 | 0 | 2.17M | 0 | 1.09M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | 1.96K | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 59.08K | 78.54M | 93.95K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 119.58K | 0 | 92.02K | 0 | 0 | 152.06K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.72M | 4.42B | 0 | 0 | 0 | 4.14M | 3.4M | 4.44M | 3.78M | 1.56M | 2.09M | 2.85M | 0 | 2.75M | 0 | 5.17M | 2.92M | 0 | 1.64M | 0 |
| Current Ratio | 1.87x | 2.40x | 3.33x | 3.52x | 4.86x | 5.83x | 8.31x | 7.67x | 9.98x | 16.18x | 21.05x | 16.92x | 19.75x | 20.99x | 19.76x | 12.38x | 22.01x | 31.26x | 42.75x | 30.55x |
| Quick Ratio | 1.87x | 2.40x | 3.33x | 3.52x | 4.86x | 5.83x | 8.31x | 7.67x | 9.98x | 16.18x | 21.05x | 16.92x | 19.75x | 20.99x | 19.76x | 12.38x | 22.01x | 31.26x | 42.75x | 30.55x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 13.52K | 33.42K | 52.84K | 93.95K | 54.69K | 15.56K | 61.5K | 106.52K | 150.71K | 140.63K | 0 | 0 | 0 | 13.3K | 52.89K | 92.02K | 130.71K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 13.52K | 33.42K | 52.84K | 93.95K | 54.69K | 15.56K | 61.5K | 106.52K | 150.71K | 140.63K | 0 | 0 | 0 | 13.3K | 52.89K | 92.02K | 130.71K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.78M | 4.5B | 4.04M | 4.9M | 4.32M | 4.38M | 3.7M | 4.66M | 3.97M | 2.74M | 2.36M | 3.17M | 2.93M | 2.8M | 3.14M | 5.3M | 3.09M | 2.38M | 1.88M | 2.82M |
| Total Debt | 59.08K | 78.54M | 93.95K | 145.04K | 194.93K | 243.66K | 291.24K | 218.7K | 193.58K | 234.47K | 274.53K | 313.86K | 260.22K | 52.89K | 92.02K | 130.71K | 168.49K | 204.95K | 240.98K | 276.6K |
| Net Debt | -4.86M | -4.34B | -8.3M | -5.92M | -6.18M | -7.27M | -7.81M | -12.76M | -18.16M | -21.7M | -25.3M | -28.11M | -32.76M | -37.15M | -39.71M | -43.23M | -46.48M | -51.32M | -54.43M | -61.08M |
| Debt / Equity | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 3.45M | 6.53B | 9.59M | 12.52M | 16.78M | 21.19M | 26.6M | 30.93M | 35.77M | 40.91M | 45.41M | 48.26M | 52.58M | 56.04M | 59.03M | 61.08M | 65.32M | 71.57M | 75.73M | 79.61M |
| Equity Growth % | -79.46% | 30739.6% | -63.96% | -59.52% | -53.09% | -48.21% | -41.43% | -35.91% | -31.97% | -27% | -23.06% | -20.98% | -19.51% | -21.7% | -22.06% | -23.28% | -20.09% | 263.33% | 251.08% | 242.75% |
| Book Value per Share | 0.31 | 599.58 | 0.88 | 1.16 | 1.56 | 1.96 | 2.47 | 2.87 | 3.33 | 3.79 | 4.18 | 4.44 | 4.84 | 5.16 | 5.45 | 5.64 | 6.01 | 6.40 | 6.77 | 7.12 |
| Total Shareholders' Equity | 3.45M | 6.53B | 9.59M | 12.52M | 16.78M | 21.19M | 26.6M | 30.93M | 35.77M | 40.91M | 45.41M | 48.26M | 52.58M | 56.04M | 59.03M | 61.08M | 65.32M | 71.57M | 75.73M | 79.61M |
| Common Stock | 1.13K | 1.13M | 1.1K | 1.08K | 1.08K | 1.08K | 1.08K | 1.08K | 1.08K | 1.07K | 1.09K | 1.09K | 1.09K | 1.09K | 1.09K | 1.08K | 1.08K | 1.11K | 1.12K | 1.12K |
| Retained Earnings | -96.47M | -93.15B | -89.07M | -84.89M | -80.56M | -76.03M | -70.15M | -65.64M | -60.69M | -55.24M | -51.06M | -47.9M | -43.15M | -39.28M | -35.9M | -33.64M | -29.14M | -25.02M | -21.48M | -17.43M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -35.64K | 25.43M | 40.33K | 48.04K | 131.73K | 153.99K | -25.26K | -6.58K | 1.86K | -107.46K | -138.79K | -261.84K | -299.68K | -371.39K | -435.04K | -348.48K | -311.47K | -92.69K | -102.69K | -47.56K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |